A Study of Ponsegromab in People With Heart Failure
Status:
Not yet recruiting
Trial end date:
2024-09-13
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to compare the effects of study medicine
(Ponsegromab/PF-06946860) with a placebo (A pill that looks like the study medicine but does
not contain the active medicine) to find out if the study medicine is better than the placebo
(a pill that looks like the study medicine but does not contain the active medicine) for
treatment of symptoms related to heart failure. Participants will not know which treatment
group they are assigned to. All participants in this study will receive the study medicine or
placebo by shots under the skin every four weeks. People may be able to participate in this
study if they have the heart failure. Participants will take part in this study for about 9
months. During this time participants will visit the study clinic once a month.